Orgonex becomes part of Demcon group

Venture Challenge alumnus Orgonex, Spin-off from Utrecht University who is bringing an innovative bioreactor to market, found in Demcon, a high-tech developer of innovative technologies, the strong and reliable partner to support the necessary product development and investment.

By joining the Demcon life sciences & health division, Orgonex becomes part of a division with deep expertise in biotechnology, alongside companies like Sync Biosystems, Scinus Cell Expansion B.V. and ReGEN Biomedical. Combined with Demcon’s extensive competences and experience in this field, Orgonex sees a bright future ahead and is very excited to what this acquisition will bring!

Orgonex relocated their operations to Zeist, where they now share facilities with Scinus. This integration allows for seamless collaboration—leveraging shared expertise, resources, and talent.

Michiel Jannink, Vice President of Demcon Life Sciences & Health, shares:
“𝘈𝘧𝘵𝘦𝘳 15+ 𝘺𝘦𝘢𝘳𝘴 𝘪𝘯 𝘭𝘪𝘧𝘦 𝘴𝘤𝘪𝘦𝘯𝘤𝘦𝘴 & 𝘩𝘦𝘢𝘭𝘵𝘩, 𝘋𝘦𝘮𝘤𝘰𝘯 𝘩𝘢𝘴 𝘣𝘶𝘪𝘭𝘵 𝘴𝘵𝘳𝘰𝘯𝘨 𝘦𝘹𝘱𝘦𝘳𝘵𝘪𝘴𝘦 𝘪𝘯 𝘮𝘦𝘥𝘪𝘤𝘢𝘭 𝘢𝘯𝘥 𝘣𝘪𝘰𝘳𝘦𝘢𝘤𝘵𝘰𝘳 𝘵𝘦𝘤𝘩𝘯𝘰𝘭𝘰𝘨𝘺. 𝘚𝘶𝘱𝘱𝘰𝘳𝘵𝘪𝘯𝘨 𝘖𝘳𝘨𝘰𝘯𝘦𝘹 𝘢𝘭𝘪𝘨𝘯𝘴 𝘱𝘦𝘳𝘧𝘦𝘤𝘵𝘭𝘺 𝘸𝘪𝘵𝘩 𝘰𝘶𝘳 𝘷𝘪𝘴𝘪𝘰𝘯 𝘵𝘰 𝘤𝘰𝘷𝘦𝘳 𝘵𝘩𝘦 𝘦𝘯𝘵𝘪𝘳𝘦 𝘣𝘪𝘰𝘵𝘦𝘤𝘩𝘯𝘰𝘭𝘰𝘨𝘺 𝘤𝘩𝘢𝘪𝘯—𝘧𝘳𝘰𝘮 𝘤𝘦𝘭𝘭 𝘤𝘶𝘭𝘵𝘪𝘷𝘢𝘵𝘪𝘰𝘯 𝘵𝘰 𝘵𝘪𝘴𝘴𝘶𝘦 𝘢𝘯𝘥 𝘰𝘳𝘨𝘢𝘯𝘰𝘪𝘥 𝘱𝘳𝘰𝘥𝘶𝘤𝘵𝘪𝘰𝘯. 𝘞𝘪𝘵𝘩 𝘖𝘳𝘨𝘰𝘯𝘦𝘹’𝘴 𝘵𝘦𝘤𝘩𝘯𝘰𝘭𝘰𝘨𝘺, 𝘸𝘦 𝘢𝘳𝘦 𝘵𝘢𝘬𝘪𝘯𝘨 𝘵𝘩𝘦 𝘯𝘦𝘹𝘵 𝘴𝘵𝘦𝘱 𝘪𝘯 𝘵𝘩𝘦 𝘨𝘳𝘰𝘸𝘪𝘯𝘨 𝘰𝘳𝘨𝘢𝘯𝘰𝘪𝘥 𝘮𝘢𝘳𝘬𝘦𝘵, 𝘥𝘳𝘪𝘷𝘪𝘯𝘨 𝘪𝘯𝘯𝘰𝘷𝘢𝘵𝘪𝘰𝘯 𝘪𝘯 𝘮𝘦𝘥𝘪𝘤𝘢𝘭, 𝘣𝘪𝘰𝘵𝘦𝘤𝘩𝘯𝘰𝘭𝘰𝘨𝘪𝘤𝘢𝘭, 𝘢𝘯𝘥 𝘱𝘩𝘢𝘳𝘮𝘢𝘤𝘦𝘶𝘵𝘪𝘤𝘢𝘭 𝘳𝘦𝘴𝘦𝘢𝘳𝘤𝘩.”

Read the full press release here: https://lnkd.in/eHDkWN8Q